Carigent Therapeutics
New Haven
About Carigent Therapeutics
Carigent Therapeutics is a biotechnology company that develops therapeutic agents. It offers a drug delivery platform for releasing therapeutic agents, targeting therapy to physiological sites, tethering surface ligands, and combining multiple agents. The company’s products are used in various applications such as genetic, systemic, and oncology diseases. Carigent Therapeutics was incorporated in 2006 and is based in New Haven, Connecticut, United States.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2007)
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/carigent-therapeutics-1528129 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.